Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomerieux 69 Marcy L'Etoile (BMXMF)

Biomerieux 69 Marcy L'Etoile (BMXMF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biomerieux 69 Marcy L'Etoile 376 Chemin De l`Orme Marcy l'Etoile I0 69280 FRA

www.biomerieux.com Employees: 14,600 P: 33-04-78-87-20-00

Sector:

Medical

INDUSTRY GROUPING:

Medical Services

Description:

bioM'rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM'rieux S.A. is based in Marcy L Etoile, France.

Key Statistics

Overview:

Market Capitalization, $K 14,802,226
Enterprise Value, $K 14,846,486
Shares Outstanding, K 118,361
Float, K 118,361
% Float 100.00%
Short Interest, K 221
Short Float 0.19%
Days to Cover 999.99
Short Volume Ratio 1.00
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 4,307 M
Annual Net Income, $ 467,680 K
EBIT, $ 0 K
EBITDA, $ 700,010 K

Growth:

1-Year Return 12.75%
3-Year Return 18.37%
5-Year Return -8.16%
5-Year Revenue Growth 43.76%
5-Year Earnings Growth 52.71%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/06/26
Earnings Per Share ttm 0.00
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 06/06/14
Dividend Payout Ratio 0.00%

BMXMF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 10.86%
Debt/Equity 0.13
Price/Sales N/A
Price/Cash Flow 27.91
Price/Book 3.31
Book Value/Share 37.77
Interest Coverage 119.30
60-Month Beta 0.85
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar